• Aminopeptidase Selectivity and ACE Inhibitor Action

  2026-09-20

  The 1992 study by Tieku and Hooper re-evaluated how bestatin and structurally distinct metallopeptidase inhibitors affect three porcine kidney aminopeptidases. Its central contribution was to show that inhibitor class strongly influences selectivity: conventional carboxyalkyl and phosphoryl ACE inhibitors spared AP-A, AP-N, and AP-W, whereas several sulfhydryl ACE inhibitors inhibited AP-W.

• Dynasore Workflows for Endocytosis Research

  2026-09-19

  Dynasore is a reversible, cell-permeable dynamin GTPase inhibitor for separating dynamin-dependent uptake from parallel internalization routes. This guide translates infection-model evidence into practical workflows for endocytosis research, synaptic vesicle studies, trafficking assays, and pathway troubleshooting.

• Cyclopamine: From Hedgehog Biology to PTC Translation

  2026-09-18

  Cyclopamine is more than a Hedgehog pathway probe: emerging papillary thyroid carcinoma data connect Smoothened inhibition with APOC1-dependent tumor biology. This translational perspective examines mechanism, validation strategy, formulation, developmental liabilities, and the path from pathway perturbation to biomarker-informed cancer research.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-09-18

  Peramangalam and colleagues identify a previously unrecognized MYCN enhancer and define eIF4G1 as a downstream survival effector in inv(16) acute myeloid leukemia. By integrating transcriptomic analysis, regulatory-element studies, leukemia models, and patient-derived xenografts, the study provides a mechanistic framework for understanding how N-MYC sustains this AML subtype.

• NHS-Biotin and the Next Era of Protein Design

  2026-09-17

  NHS-Biotin is more than a labeling reagent: it can serve as an analytical bridge between protein engineering, assembly-state characterization, detection, and purification. This article examines how N-hydroxysuccinimido biotin chemistry can complement emerging peptidisc-assisted nanobody multimerization while keeping translational limitations in view.

• Phosphatase Inhibitor Cocktail 1: Workflow Guide

  2026-09-17

  Phosphatase Inhibitor Cocktail 1 is a 100X DMSO-based alkaline phosphatase inhibitor mixture for protein phosphorylation preservation during sample preparation. Its defined composition and storage specifications support phosphoproteomic analysis, Western blotting, and related biochemical workflows, but assay-specific validation remains essential.

• Pcbp1, Mitochondria, and B Cell Immunity

  2026-09-16

  Zhu et al. identify the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity in B cells. The study connects Pcbp1–Fdxr regulation with complex I function, mitochondrial reactive oxygen species, protein translation, IgM production, and germinal center antibody responses.

• Midecamycin: Practical Assays for Resistance Research

  2026-09-16

  Midecamycin is a targeted bacterial protein synthesis inhibitor for Gram-positive screening, ribosome-focused studies, and macrolide resistance workflows. Its susceptibility to multiple glycosylation modifications makes it especially useful for connecting whole-cell antimicrobial results with enzyme-mediated antibiotic inactivation.

• Ertugliflozin (PF-04971729): Translational Strategy

  2026-09-15

  A thought-leadership guide to using Ertugliflozin (PF-04971729) in diabetes mellitus research, renal glucose transport studies, weight-loss investigations, and exploratory intestinal inflammation models.

• JHU-083: A Compartment-Aware Assay Strategy

  2026-09-15

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for dissecting glutaminase-dependent glutamate biology. This article develops an assay framework that separates cell-selective glutamate effects from downstream oxidative-stress signals, using recent GSTA1 findings to sharpen experimental interpretation.

• C. difficile Mucus Responses in a Human Intestinal Model

  2026-09-14

  The reference study introduces a primary human intestinal epithelial cell model that produces physiologic mucus and enables direct analysis of Clostridioides difficile behavior without a resident microbiota. Integrated growth, transcriptomic, biophysical, and metabolic analyses show that mucus is not only a barrier but also a niche that can promote pathogen growth, biofilm formation, and flexible metabolic adaptation.

• Steroid Lysis of Protoplasts: Spermine Protection

  2026-09-14

  Smith and Shay used osmotically fragile Sarcina lutea protoplasts to distinguish direct membrane injury from indirect effects of synthetic antimicrobial steroids. Their central finding was that spermine tetrahydrochloride strongly protected protoplasts from steroid-induced lysis, supporting a membrane-centered mechanism and illustrating how protoplast assays can dissect antimicrobial action.

• Biotin (Vitamin B7): Mechanism & Workflows

  2026-09-13

  Biotin, also called Vitamin B7 or Vitamin H, is a water-soluble cofactor for five human carboxylases and a high-affinity ligand for avidin and streptavidin. This article separates its metabolic functions from its use in protein biotinylation, defines practical solvent and storage boundaries, and explains why the cited shrimp STING study does not establish a direct role for biotin.

• Asunaprevir (BMS-650032) HCV Research Workflow

  2026-09-12

  Build more reliable HCV protease studies with Asunaprevir (BMS-650032), combining genotype-aware dose response, replication readouts, and orthogonal viability controls. The workflow also adapts a high-throughput assay principle from chromatin biology without confusing mechanistic evidence across disease areas.

• Bobcat339 for TET-Driven DNA Methylation

  2026-09-11

  Bobcat339 offers a practical chemical perturbation strategy for connecting TET1/TET2 activity with DNA methylation, enhancer state, and osteogenic phenotypes. This workflow translates the UHRF1–TGM2 findings in senile osteoporosis into dose-response, molecular, and multi-omics experiments while emphasizing controls and assay-specific optimization.

7954 records 1/531 page Next 12345 下5页 Last page